VanEck Pharmaceutical ETF
PPH
PPH
41 hedge funds and large institutions have $55.8M invested in VanEck Pharmaceutical ETF in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
-5
Holders Change %
-10.87%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
12
Closed
10
Calls
$1.74M
Puts
$6.77M
Net Calls
-$5.03M
Net Calls Change
-$5.93M
Top Buyers
| 1 |
WWM
Western Wealth Management
Golden,
Colorado
|
+$8.37M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$3.93M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.28M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.8M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.64M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$16.8M |
| 2 |
Cerity Partners
New York
|
-$1.3M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.2M |
| 4 |
FA
Fortis Advisors
Wayne,
Pennsylvania
|
-$763K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$310K |
